(ed:..this one is a clear example of the madness of allowing big-pharma to set the prices for their pills/potions/unctions..
solution?: nationalise the bastards..!..let the governments set the prices – in the interests of the citizens..
big-pharma joins big-oil as something that must go – be evolved away from..)
The cost of lomustine, a veteran cancer drug, have skyrocketed after a startup bought the rights to it and hiked prices 1,400 percent.
According to the Wall Street Journal, lomustine was sold by Bristol-Myers Squib for years under the brand name CeeNU at a price of about $50 a capsule for the highest dose.
The drugmaker sold lomustine in 2013 to a little-known Miami startup called NextSource which proceeded to hike lomustine’s price nine times since.
It now charges about $768 per pill for the medication.
According to an analysis done for the Journal by Truveen Health Analytics and Elsevier – NextSource this year raised prices for the drug – which it rebranded as Gleostine – by 12 percent in November following a 20 percent increase in August.